Autor(es):
Alves, Luísa ; Cardoso, Sandra ; Silva, Dina ; Mendes, Tiago ; Maroco, J. P. ; Nogueira, Joana ; Lima, Marisa ; Pereira, Miguel Tábuas ; Baldeiras, Inês ; Santana, Isabel ; De Mendonça, Alexandre ; Guerreiro, Manuela
Data: 2020
Identificador Persistente: http://hdl.handle.net/10400.12/7688
Origem: Repositório do ISPA - Instituto Universitário
Descrição
Patients diagnosed with amnestic mild cognitive impairment (aMCI) are at high risk of progressing to dementia. It became possible, through the use of biomarkers, to diagnose those patients with aMCI who have Alzheimer's disease. However, it is presently unfeasible that all patients undergo biomarker testing. Since neuropsychological testing is required to make a formal diagnosis of aMCI, it would be interesting if it could be used to predict the amyloid status of patients with aMCI.